Prevention and treatment of cryptosporidiosis in immunocompromised patients

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2007, Pages

  Abubakar, Ibrahim ^a   Aliyu, S H ^b   Arumugam, C ^b   Hunter, P R ^b   Usman, N K ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NONE

Author keywords

*Immunocompromised host; Antiprotozoal agents *therapeutic use ; Cryptosporidiosis *drug therapy; prevention control ; Diarrhea *drug therapy; parasitology; prevention control ; Randomized controlled trials as topic

Indexed keywords

BOVINE DIALYZABLE LEUKOCYTE EXTRACT; BOVINE HYPERIMMUNE COLOSTRUM; DIDANOSINE; IMMUNOMODULATING AGENT; LEUKOCYTE EXTRACT; NITAZOXANIDE; PAROMOMYCIN; PLACEBO; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SPIRAMYCIN; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CALCULATION; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; COLOSTRUM; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EMBASE; HUMAN; IMMUNE DEFICIENCY; MEDLINE; NAUSEA; OUTCOME ASSESSMENT; REVIEW; TREATMENT OUTCOME; VOMITING;

EID: 33947263004     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004932.pub2     Document Type: Review

References (45)

1. Amadi 2002 {published data only} Amadi, B, Mwiya, M, Musuku, J, Watuka, A, Sianongo, S, Ayoub, A, & Kelly, P. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 2002;360(9343):1375-1380.
2. Hewitt 2000 {published data only} Hewitt, R. G, Yiannoutsos, C. T, Higgs, E. S, Carey, J. T, Geiseler, P. J, Soave, R, Rosenberg, R, Vazquez, G. J, Wheat, L. J, Fass, R. J, Antoninievic, Z, Walawander, A. L, Flanigan, T. P, & Bender, J. F. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group. Clin. Infect. Dis 2000;31 (4):1084-1092.
3. McMeeking 1990 {published data only} McMeeking, A, Borkowsky, W, Klesius, P. H, Bonk, S, Holzman, R. S, & Lawrence, H. S. A controlled trial of bovine dialyzable leukocyte extract for cryptosporidiosis in patients with AIDS. J. Infect. Dis 1990;161(1):108-112.
4. Nord 1990 {published data only} Nord, J, Ma, P, DiJohn, D, Tzipori, S, & Tacket, C. O. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS 1990;4(6):581-584.
5. Rossignol 1998 {published data only} Rossignol, J. F, Hidalgo, H, Feregrino, M, Higuera, F, Gomez, W. H, Romero, J. L, Padierna, J, Geyne, A, & Ayers, M. S. A double-' blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans.R.Soc.Trop.Med Hyg 1998;92(6):663-666.
6. White 1994 {published data only} White, A.C, Jr, Chappell, C. L, Hayat, C. S, Kimball, K. T, Flanigan, T. P, & Goodgame, R. W. Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J. Infect. Dis 1994;179(2):419-424.
7. Wittenberg 1989 {published data only} Wittenberg, D. F, Miller, N. M, & van den, E. J. Spiramycin is not effective in treating cryptosporidium diarrhea in infants: results of a double-blind randomized trial. J. Infect. Dis 1989;159(1):131-132.
8. Amenta 1999 *Amenta, M, Dalle Nogare, E. R, Colomba, C, Prestileo, T. S, Di Lorenzo, F, Fundaro, S, Colomba, A, & Ferrieri, A. Intestinal protozoa in HIV-infected patients: effect of rifaximin in Cryptosporidium parvum and Blastocystis hominis infections. J. Chemother 1999;11 (5):391-395.
9. Dionisio 1998 Dionisio, D, Orsi, A, Sterrantino, G, Meli, M, Di Lollo, S, Ibba, M. L, Trotta, M, Pozzi, M, Sani, L, & Leoncini, F. Chronic cryptosporidiosis in patients with AIDS: stable remission and possible eradication after long-term, low dose azithromycin. J. Clin. Pathol 1998;51(2):138-142.
10. Fichtenbaum 2000 Fichtenbaum, C. J, Zackin, R, Feinberg, J, Benson, C, & Griffiths, J. K. Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection. AIDS 2000;14(18):2889-2893.
11. Flanigan 1996 Flanigan, T. P, Ramratnam, B, Graeber, C, Hellinger, J, Smith, D, Wheeler, D, Hawley, P, Heath-Chiozzi, M, Ward, D. J, Brummitt, C, & Turner, J. Prospective trial of paromomycin for cryptosporidiosis in AIDS. Am J Med 1996;100(3):370-372.
12. Greenberg 1996 Greenberg, P. D, Cello. J. P. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir. Immune.Defic.Syndr.Hum. Retrovirol 1996;13(4):348-354.
13. Hellard 2001 Hellard, M. E, Sinclair, M. I, Forbes, A. B, & Fairley, C. K. A randomized, blinded, controlled trial investigating the gastrointestinal health effects of drinking water quality. Environ.Health Perspect 2001;109(8):773-778.
14. Kadappu 2002 Kadappu, K. K, Nagaraja, M. V, Rao, P. V, & Shastry, B. A. Azithromycin as treatment for cryptosporidiosis in human immunodeficiency virus disease. J. Postgrad. Med 2002;48(3):179- 181.
15. Okhuysen 1997 Okhuysen, P.C, Chappell, C. L, Crabb, J, Valdez, L.M, Douglass, E. T, & DuPont, H. L. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin. Infect. Dis 1998;26 (6):1324-1329.
16. Rossignol 2001 Rossignol, J. F, Ayoub, A, & Ayers, M. S. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J. Infect. Dis 2001;104(1):103-106.
17. Saez-Llorens 1989 Saez-Llorens, X, Odio, C. M, Umana, M. A, & Morales, M. V. Spiramycin vs. placebo for treatment of acute diarrhea caused by Cryptosporidium. Pediatr.Infect.Dis J 1989;8(3):136-140.
18. Smith 1998 Smith, N. H, Cron, S, Valdez, L. M, Chappell, C. L, & White, A. C, Jr. Combination drug therapy for cryptosporidiosis in AIDS. J. Infect. Dis 1998;178(3):900-903.
19. Sprinz 1998 Sprinz, E, Mallman, R, Barcellos, S, Silbert, S, Schestatsky, G, & Bem, D. D. AIDS-related cryptosporidial diarrhoea: an open study with roxithromycin. J Antimicrob.Chemother 1998;41(Suppl B):85-91.
20. Uip 1998 Uip, D. E, Lima, A. L, Amato, V. S, Boulos, M, Neto, V. A, & Bem, D. D. Roxithromycin treatment for diarrhoea caused by Cryptosporidium spp. in patients with AIDS. J Antimicrob.Chemother 1998;41 (Suppl B):93-97.
21. Woolf 1987 Woolf, G. M, Townsend, M, & Guyatt, G. Treatment of cryptosporidiosis with spiramycin in AIDS. An "N of 1" trial. J Clin.Gastroenterol 1987;9(6):632-634.
22. Abrahamsen 2004 Abrahamsen, M.S, Templeton TJ, Enomoto, S, Abrahante, JE, Zhu, G, Lancto CA, Deng M, Liu C, Widmer G, Tzipori G, Buck GA, Xu P, Bankier AT, Dear PH, Konfortov BA, Spriggs HF, Iyer L, Anantharaman V, Aravind L, Kapur V. Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science 2004;304 (5669):441-445.
23. Carr 1998 Carr A, Marriot D, Field A, Vasak E, Cooper DA. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 1998;351:256-261.
24. CDC 1995 CDC. Cryptosporidium in water: CDC guidelines on how to protect yourself. Centers for Disease Control and Prevention. AIDS Treat News 1995;227:7-8.
25. Cicirello 1997 Cicirello, H, Kehl KS, Addiss DG, Chusid MJ, Glass RI, Davis JP, Havens PL. Cryptosporidiosis in children during a massive water-borne outbreak in Milwaukee, Wisconsin: clinical, laboratory and epidemiologic findings. Epidemiol Infect 1997;119:53-60.
26. Crabb 1998 Crabb, J. Antibody-based immunotherapy for cryptosporidiosis. Adv. Parasitol 1998;40:121-149.
27. Current 1991 Current, WL, Garcia LS. Cryptosporidiosis. Clin. Microbiol. Rev 1991;4(3):325-358.
28. Fewtrell 2005 Fewtrell, L, Kaufmann RB, Kay D, Enanoria W, Haller L, Colford JM Jr. Water, sanitation, and hygiene interventions to reduce diarrhoea in less developed countries: a systematic review and meta-analysis. Lancet Infect. Dis 2005;5(1):42-52.
29. Grube 1997 Grube, H, Ramratnam B, Ley C, Flanigan TP. Resolution of AIDS associated cryptosporidiosis after treatment with indinavir. Am. J. Gastroenterol 1997;92(4):726.
30. Havelaar 2003 Havelaar A, Boonyakarnkul T, Cunliffe D, et al.Guidelines for Drinking Water Quality Water Borne Pathogens. Vol. Third Edition, WHO, 2003.
31. Hunter 2000 Hunter, PR. Advice on the response from public and environmental health to the detection of cryptosporidial oocysts in treated drinking water. PHLS Advisory Committee on Water and the Environment. Comm. Dis. Pub. Health 2000;3(1):24-27.
32. Hunter 2002 Hunter, PR, Nichols. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin. Microbiol. Rev 2002;15(1):145-154.
33. Jadad 1996 Jadad, AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control. Clin. Trials 1996;17(1):1-12.
34. Juranek 1995 Juranek, DD. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin.Infect.Dis 1995;21(Suppl 1):S57-61.
35. Kaplan 2002 Kaplan, JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm.Rep 2002;51(RR-8):1-52.
36. Mac Kenzie 1994 Mac Kenzie, WR, Hoxie NJ, Proctor ME, Gradus MS, Blair KA, Peterson DE, Kazmierczak JJ, Addiss DG, Fox KR, Rose JB. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N. Engl. J. Med 1994;331(3):161-167.
37. Maggi 2000 Maggi, P, Larocca AM, Quarto M, Serio G, Brandonisio O, Angarano G, Pastore G. Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1. Eur. J Clin. Microbiol. Infect.Dis 2000;19(3):213-217.
38. McLauchlin 2000 McLauchlin, J, Amar C, Pedraza-Diaz S, Nichols GL. Molecular epidemiological analysis of Cryptosporidium spp. in the United Kingdom: results of genotyping Cryptosporidium spp. in 1,705 fecal samples from humans and 105 fecal samples from livestock animals. J. Clin. Microbiol 2000;38(11):3984-3990.
39. Mead 2002 Mead, JR. Cryptosporidiosis and the challenges of chemotherapy. Drug Resist. Updat 2002;5(1):47-57.
40. Miao 2000 Miao, YM, Awad-El-Kariem FM, Franzen C, Ellis DS, Muller A, Counihan HM, Hayes PJ, Gazzard BG. Eradication of cryptosporidia andmicrosporidia following successful antiretroviral therapy. J.Acquir.Immune.Defic.Syndr 2000;25(2):124-129.
41. Morgan-Ryan 2002 Morgan-Ryan, UM, Fall A, Ward LA, Hijjawi N, Sulaiman I, Fayer R, Thompson RC, Olson M, Lal A, Xiao L. Cryptosporidium hominis n. sp. (Apicomplexa: Cryptosporidiidae) from Homo sapiens. J Eukaryot. Microbiol 2002;49(6):433-440.
42. Robinson 2002 Robinson, KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int, J. Epidemiol 2002;31(1):150-153.
43. Striepen 2004 Striepen, B, Pruijssers AJ, Huang J, Li C, Gubbels MJ, Umejiego NN, Hedstrom L, Kissinger JC. Gene transfer in the evolution of parasite nucleotide biosynthesis. Proc. Natl. Acad. Sci. U.S.A 2004; 101(9):3154-3159.
44. Theodos 1998 Theodos, CM, Griffiths JK, D'Onfro J, Fairfield A, Tzipori S. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicrob. Agents Chemother 1998;42(8):1959-1965.
45. Umejiego 2004 Umejiego, NN, Li C, Riera T, Hedstrom L, Striepen B. Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design. J. Biol. Chem 2004;279(39):40320-40327.